Christopher Brenzel

Christopher Brenzel is an experienced professional in sales and business development within the biotechnology sector. Currently serving as the Sales and Business Development Manager at GemPharmatech since April 2024, Christopher previously held key roles at Hera BioLabs, including Senior Director of Business Development for Gene Editing Solutions and Business Development Manager from January 2016 to April 2024. Prior experience includes technical sales specialization at Transposagen Biopharmaceuticals and internships in sales and business development. Christopher holds a Bachelor of Science degree in Biology from the University of Notre Dame, attained in 2014.